{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-076282","form_type":"8-K12B","ticker":"KNSA","cik":"0001730430","company_name":"Kiniksa Pharmaceuticals International, plc","filed_at":"2024-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.781992+00:00","generated_at":"2026-06-01T00:43:01.545797+00:00","sec_items":["1.01","3.01","3.02","3.03","5.03","5.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Kiniksa completes redomiciliation from Bermuda to UK, shares trade on Nasdaq under same symbol KNSA","bullets":["Effective June 27, 2024, Kiniksa redomiciled to UK via Bermuda court-approved scheme of arrangement.","Shareholders received one-for-one exchange of shares; ~40.4M Class A, 1.8M B, 12.8M A1, 16.1M B1 ordinary shares issued.","Class A Ordinary Shares continue trading on Nasdaq under symbol KNSA as of June 28, 2024.","Same executive officers and directors continue; indemnification agreements and equity plans assumed.","Depositary receipts issued for shares not directly eligible for DTC transfer to avoid UK stamp duty."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-076282","json":"https://secwatch.observer/filing/0001104659-24-076282.json","markdown":"https://secwatch.observer/filing/0001104659-24-076282.md","text":"https://secwatch.observer/filing/0001104659-24-076282.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1730430/000110465924076282/0001104659-24-076282-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1730430/000110465924076282/tm2417839d12_8k12b.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:43:01.545797+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}